152 related articles for article (PubMed ID: 20652816)
1. Intravitreal triamcinolone acetonide induced changes in the anterior segment in a pig model of branch retinal vein occlusion.
Vijayasekaran S; McAllister IL; Morgan WH; Mendis KR; McMenamin PG; Cringle SJ; Yu DY
Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):215-22. PubMed ID: 20652816
[TBL] [Abstract][Full Text] [Related]
2. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion.
McAllister IL; Vijayasekaran S; Chen SD; Yu DY
Am J Ophthalmol; 2009 May; 147(5):838-46, 846.e1-2. PubMed ID: 19211093
[TBL] [Abstract][Full Text] [Related]
3. Triamcinolone acetonide decreases outflow facility in C57BL/6 mouse eyes.
Kumar S; Shah S; Deutsch ER; Tang HM; Danias J
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1280-7. PubMed ID: 23322580
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructure of the trabecular meshwork in secondary glaucoma eyes after intravitreal triamcinolone acetonide.
Kubota T; Okabe H; Hisatomi T; Yamakiri K; Sakamoto T; Tawara A
J Glaucoma; 2006 Apr; 15(2):117-9. PubMed ID: 16633224
[TBL] [Abstract][Full Text] [Related]
5. Cytokine Levels in Experimental Branch Retinal Vein Occlusion Treated With Either Bevacizumab or Triamcinolone Acetonide.
McAllister IL; Vijayasekaran S; McLenachan S; Bhikoo R; Chen FK; Zhang D; Kanagalingam E; Yu DY
Transl Vis Sci Technol; 2024 Jun; 13(6):13. PubMed ID: 38899953
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.
Ozkiris A; Evereklioglu C; Erkilic K; Dogan H
Eye (Lond); 2006 Jan; 20(1):13-7. PubMed ID: 15723039
[TBL] [Abstract][Full Text] [Related]
7. Inner Retinal Changes in Acute Experimental BRVO Treated With Bevacizumab or Triamcinolone Acetonide.
McAllister IL; Vijayasekaran S; Bhikoo R; Chen FK; Zhang D; Kanagalingam E; McLenachan S; Yu DY
Transl Vis Sci Technol; 2023 Feb; 12(2):11. PubMed ID: 36753186
[TBL] [Abstract][Full Text] [Related]
8. Vehicle used for triamcinolone acetonide is toxic to ocular tissues of the pigmented rabbit.
Zhengyu S; Fang W; Ying F
Curr Eye Res; 2009 Sep; 34(9):769-76. PubMed ID: 19839870
[TBL] [Abstract][Full Text] [Related]
9. Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density.
Kai W; Yanrong J; Xiaoxin L
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1152-9. PubMed ID: 16453123
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
11. Triamcinolone intravitreal injection and intraocular pressure in macular edema associated with retinal vein occlusion.
Wei Y; Wang HZ; Chen FH; Wang RS; Yang XG
Eye Sci; 2012 Dec; 27(4):182-7. PubMed ID: 23225839
[TBL] [Abstract][Full Text] [Related]
12. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
Higashiyama T; Sawada O; Kakinoki M; Sawada T; Kawamura H; Ohji M
Acta Ophthalmol; 2013 Jun; 91(4):318-24. PubMed ID: 22132711
[TBL] [Abstract][Full Text] [Related]
13. Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.
Hirano Y; Ito T; Nozaki M; Yasukawa T; Sakurai E; Yoshida M; Ogura Y
Jpn J Ophthalmol; 2009 Sep; 53(5):519-22. PubMed ID: 19847609
[TBL] [Abstract][Full Text] [Related]
14. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Jonas JB; Kreissig I; Kamppeter B; Degenring RF
Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
Cheng KC; Wu WC; Chen KJ
Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide.
Danis RP; Bingaman DP; Yang Y; Ladd B
Ophthalmology; 1996 Dec; 103(12):2099-104. PubMed ID: 9003344
[TBL] [Abstract][Full Text] [Related]
17. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
Yamashita T; Uemura A; Kita H; Sakamoto T
J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
[TBL] [Abstract][Full Text] [Related]
18. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
Sohn HJ; Han DH; Lee DY; Nam DH
Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Oct; 83(5):600-4. PubMed ID: 16188000
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
